Along with the detection of leukemia-reactive CD8+ T cells, we observed an increase in CD4+CD25+Foxp3+ T cells after DNR plus ARA-C chemotherapy (Figure 1A) with a peak at day 21. The gene discussed is FOXP3; the disease is leukemia.